Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Xiaochun Zhu et al.|Blood|2017Cited by 296
Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: <scp>BMT CTN</scp> 1102Rachel Cusatis, Kathryn E. Flynn, Michael J. Martens et al.|American Journal of Hematology|2022Cited by 19